London – June 28, 2018 – Cooley advised Acelity, a global leader in wound care, on the acquisition of Crawford Healthcare. Justin Stock, Cooley’s UK managing partner, led the team advising Acelity.
Crawford Healthcare is a recognized leader in developing and commercializing innovative treatments for the care and repair of skin. Through the combination, Acelity has expanded its portfolio of advanced wound dressings, strengthening its position as global leader and creating the world’s most expansive wound care portfolio.
Acelity is headquartered in San Antonio, Texas, and employs nearly 5,000 people worldwide. Its subsidiary, KCI, is the most trusted brand in advanced wound care with products available in more than 90 countries.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.